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A B S T R A C T
We report a new second generation sequencing method for identiﬁcation micro-RNA (miRNA) that can
be used to identify body ﬂuids and tissues. Principal component analysis of 10 miRNAs with high
expression in 16 samples of blood, saliva and semen showed clear differences in the expression of miRNA
in the investigated tissues. We expect that the method can also be used for identiﬁcation of other
miRNAs that can be used for identifying other body ﬂuids and tissues. We also expect that the method
can be used for identiﬁcation of body ﬂuids and tissues in practical forensic genetic case work.
 2013 Elsevier Ireland Ltd. All rights reserved.
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When an STR proﬁle is obtained from a crime scene sample,
additional knowledge of the body ﬂuid from which the sample was
obtained, may be of interest. Many such tests are available. We
have explored the use of second generation sequencing of miRNA
for the identiﬁcation of body ﬂuids and tissues within the ﬁeld of
forensic genetics.
2. Materials and methods
2.1. Samples
Four blood, ﬁve saliva and seven semen samples were obtained
from one female and nine male volunteers. RNAlater1 (Ambion,
USA) was added to the blood samples according to the instructions
of the manufacturer. Saliva samples were collected in Oragene1-
RNA RE-100 collection tubes (DNA Genotek, Ottawa, ON, Canada).
Semen ejaculates were collected in Oragene1-RNA RE-100
collection tubes (DNA Genotek, Ottawa, ON, Canada). The samples
were stored at 20 8C until investigation.* Corresponding author. Tel.: +45 28756123.
E-mail address: benjamin.hjort@sund.ku.dk (B.B. Hjort).
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http://dx.doi.org/10.1016/j.fsigss.2013.10.1052.2. Extraction of RNA, ampliﬁcation and sequencing
miRNA/RNA was extracted with RiboPureTM-Blood Kit (Invitro-
gen, USA) from blood, with mirVanaTM miRNA Isolation Kit
(Invitrogen, USA) from saliva and with NucleoSpin1 miRNA
extraction kit (Macherey-Nagel, Germany) from semen. RNA
was poly-adenylated using the Poly-A Polymerase Tailing Kit
(Epicentre Biotechnologies, Wisconsin, USA). RNA was reverse
transcribed into cDNA using PrimeScript Reverse TranscriptaseTM
(Takara Bio Inc., Otsu, Shiga, Japan). Puriﬁcation and size selection
of cDNA was performed by gel electrophoresis using 10%
polyacrylamide gels followed by overnight phenol extraction.
The cDNA was ligated to a linker using T4 DNA Ligase (Thermo
Scientiﬁc, Massachusetts, USA). PCR was performed with Phusion1
High-Fidelity DNA Polymerase (New England Biolabs, Massechu-
setts, USA) to amplify the library. PCR products were puriﬁed using
AMPure XP (Beckman-Coulter). Sequencing by synthesis was
performed on Illumina Hiseq 2000 following the recommendations
of the manufacturer.
2.3. Data analysis
Data analysis was done using Flexbar [1] and MiRanalyser [2].
Massively parallel sequencing with SGS generates large numbers
of data, some of which is irrelevant. Therefore, the sequence data
was trimmed by the following procedures: (1) Sequences were
inspected from the 30end and recorded when the ﬁrst base with a
Phred score > 19 was observed; (2) thereafter, the poly-A tails, (3)
Fig. 1. Principal component analysis of 10 miRNAs in 16 samples of blood, saliva and
semen.
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scores < 20 were removed. The remaining high-quality reads were
Bowtie mapped to the miRBase [3]. The principal component
analysis was made in R. We used Logit transformed rates between
the speciﬁc and total numbers of high quality miRNA reads.
3. Results and discussion
For each miRNA detected in a sample, the rate of the speciﬁc,
high-quality miRNAs compared to the total number of detected
high-quality miRNAs of the sample was calculated. A total of 10
miRNAs with rates >10% for at least one of the samples were
selected (miR-4301, miR-451, miR486-5p, miR-223, miR-29c, miR-
4286, miR-16, miR 205, miR-1246 and miR-1274a) for further
analysis. Fig. 1 shows a principal component analysis of Logittransformed rates of the 10 miRNAs in 16 samples of blood, saliva
and semen.
4. Conclusions
The expression levels of the chosen set of miRNAs efﬁciently
separated the investigated tissues (Fig. 1), indicating that the
miRNA expression proﬁles of blood, semen and saliva are very
different. The method is a promising tool for identiﬁcation and
quantiﬁcation of miRNAs that can be used for body ﬂuid and tissue
identiﬁcation. It seems likely that blood, semen and saliva can be
identiﬁed in forensic genetic case work with a quite low number of
miRNA markers. Moreover, identiﬁcation of additional body ﬂuids
and tissues is anticipated to be possible with a limited number of
miRNA markers.
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